Alejandro Llanos-Chea
Overview
Explore the profile of Alejandro Llanos-Chea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
145
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davis T, Rogers B, Llanos-Chea A, Krasaelap A, Banks D, Ambartsumyan L, et al.
J Pediatr Gastroenterol Nutr
. 2024 Jul;
79(3):541-549.
PMID: 39010786
Objectives: Ineffective esophageal motility (IEM) on high-resolution manometry (HRM) is not consistently associated with specific clinical syndromes or outcomes. We evaluated the prevalence, clinical features, management, and outcomes of pediatric...
2.
Katz D, Curia S, Fifi A, Febo-Rodriguez L, Llanos-Chea A
JPGN Rep
. 2023 Nov;
4(4):e390.
PMID: 38034445
Congenital glucose-galactose malabsorption is a rare cause of life-threatening diet-induced diarrhea in infants. Mutations in the gene, which encodes for the sodium-dependent glucose transporter, result in large-volume diarrhea due to...
3.
Riera-Canales C, Llanos-Chea A
Curr Opin Pediatr
. 2023 May;
35(5):585-589.
PMID: 37255048
Purpose Of Review: This is an overview of the effects of COVID-19 in the gastrointestinal tract in children, and current evidence of the impact of COVID-19 in pediatric patients with...
4.
Cheung D, Katz D, Webster-Carrion A, Saad A, Fifi A, Llanos-Chea A, et al.
J Pediatr Gastroenterol Nutr
. 2022 Jun;
75(6):e117-e118.
PMID: 35653423
No abstract available.
5.
Wallace C, Sinopoulou V, Gordon M, Akobeng A, Llanos-Chea A, Hungria G, et al.
Cochrane Database Syst Rev
. 2022 Mar;
3:CD014257.
PMID: 35349168
Background: Functional constipation is defined as chronic constipation with no identifiable underlying cause. It is a significant cause of morbidity in children, accounting for up to 25% of visits to...
6.
Katz D, Saps M, Llanos-Chea A, Febo-Rodriguez L
J Pediatr Gastroenterol Nutr
. 2021 Oct;
74(2):e40-e41.
PMID: 34596607
No abstract available.
7.
Nickerson K, Llanos-Chea A, Ingano L, Serena G, Miranda-Ribera A, Perlman M, et al.
Microbiol Spectr
. 2021 Jun;
9(1):e0000321.
PMID: 34106568
Gastrointestinal infections cause significant morbidity and mortality worldwide. The complexity of human biology and limited insights into host-specific infection mechanisms are key barriers to current therapeutic development. Here, we demonstrate...
8.
Llanos-Chea A, Shapiro J, Winter R, Jerger L, Menz T, Gibson M, et al.
Dig Dis Sci
. 2021 Feb;
67(1):252-258.
PMID: 33595782
Background: Inflammatory bowel diseases (IBD) are often treated with anti-tumor necrosis factor alpha (anti-TNFα) medications. Concomitant treatment of IBD with anti-TNFα agents and immunomodulators appears to be associated with an...
9.
Velasco-Benitez C, Llanos-Chea A, Saps M
Neurogastroenterol Motil
. 2020 Oct;
33(8):e14015.
PMID: 33094889
Background: One of the criteria for functional constipation (FC) in Rome IV criteria is the presence of hard or painful bowel movements. In adults and children, the Rome IV criteria...
10.
Gipson K, Nickerson K, Drenkard E, Llanos-Chea A, Dogiparthi S, Lanter B, et al.
Infect Immun
. 2020 Jul;
88(10).
PMID: 32661122
Throughout the course of infection, many pathogens encounter bactericidal conditions that threaten the viability of the bacteria and impede the establishment of infection. Bile is one of the most innately...